Exclusive: HHS launches project to speed up clinical trials
Summary
The Department of Health and Human Services (HHS) is starting a new program called SURPASS to make clinical trials faster and cheaper. The program aims to improve how new drugs are tested by using new technology and better processes over the next five years.Key Facts
- The SURPASS program was announced by Health Secretary Robert F. Kennedy, Jr., ARPA-H Director Alicia Jackson, CMS Administrator Mehmet Oz, and FDA Acting Commissioner Kyle Diamantas.
- SURPASS stands for Simulation-augmented, Real-time Platform Adaptive Seamless Trials.
- The program will fund teams that include drug sponsors to develop faster and more efficient clinical trials.
- The goal is to allow faster trials with fewer patients and to analyze data during the trial instead of after it ends.
- Automation and computer predictions will be used to reduce inefficiencies and improve drug outcome forecasts.
- The FDA is involved in planning to ensure the trials meet regulatory requirements.
- The program hopes to reduce clinical trial costs by up to 10 times and cut the timeline for drug development in half or more.
- Additional projects are planned to expand trial sites, improve data systems, and help cancer patients use their data better.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
